NEW YORK (GenomeWeb) – Affymetrix reported after the close of the market Wednesday that its fourth quarter revenues increased 2 percent year over year, beating the consensus Wall Street estimate.

The Santa Clara, California-based microarray and genetic analysis products firm reported total revenues of $95.6 million for the quarter ended Dec. 31, 2015, up from $93.5 million in Q4 2014 and beating analysts' consensus estimate of $93.3 million. On a constant currency basis, Affy said its Q4 2015 revenues were up nearly 7 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.